Page 38 - Read Online
P. 38

Chandrasekar et al. Mini-invasive Surg 2021;5:33              Mini-invasive Surgery
               DOI: 10.20517/2574-1225.2021.12



               Review                                                                        Open Access



               Diagnosis and treatment of biliary malignancies:

               biopsy, cytology, cholangioscopy and stenting


               Viveksandeep Thoguluva Chandrasekar, Douglas Faigel
               Mayo Clinic, Scottsdale, AZ 85259, USA.

               Correspondence to: Prof. Douglas Faigel, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, Arizona 85259, USA. E-mail:
               faigel.douglas@mayo.edu

               How to cite this article: Chandrasekar VT, Faigel D. Diagnosis and treatment of biliary malignancies: biopsy, cytology,
               cholangioscopy and stenting. Mini-invasive Surg 2021;5:33. https://dx.doi.org/10.20517/2574-1225.2021.12

               Received: 2 Feb 2021  First Decision: 8 May 2021  Revised: 18 May 2021  Accepted: 11 Jun 2021  Available online: 17 Jun 2021

               Academic Editor: Jean-François Rey  Copy Editor: Xi-Jun Chen  Production Editor: Xi-Jun Chen

               Abstract
               Biliary tract malignancies include cancers of the intra-hepatic and extra-hepatic bile ducts. Cholangiocarcinoma is
               the predominant biliary tract malignancy with nearly 60% of them occurring in the peri-hilar region. They can
               present with biliary strictures causing jaundice but can be insidious and present late in their clinical course. Recent
               advances in imaging and other diagnostic modalities help in the earlier identification of these tumors. Diagnosis
               should be suspected in anyone presenting with jaundice with evidence of biliary ductal dilatation or in patients with
               primary sclerosing cholangitis with worsening clinical status. The diagnostic approach consists of obtaining tumor
               markers, mainly CA 19-9, imaging modalities which include computed tomography and/or magnetic resonance
               imaging to establish the level of biliary obstruction and presence or absence of mass. Tissue sampling is performed
               with endoscopic retrograde cholangiopancreatography (ERCP) guided cytology and biopsies and with endoscopic
               ultrasound (EUS) if a mass is visible on imaging. Indeterminate strictures after initial biopsies could be further
               evaluated by cholangioscopy directed biopsies. Treatment for resectable and distal bile duct cancers involves
               surgical referral, but palliative biliary drainage is the key for unresectable cancers. Metal stents are generally
               preferred for distal cancers and plastic stents for proximal cancers. EUS guided biliary drainage can be an
               alternative approach in patients with failed ERCP.

               Keywords: Cholangiocarcinoma, malignant biliary strictures, endoscopic retrograde cholangiopancreatography,
               stent, endoscopic ultrasound










                           © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                            www.misjournal.net
   33   34   35   36   37   38   39   40   41   42   43